Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Julia Annette Schulz, David M. Stresser & John Cory Kalvass. (2023) Plasma protein-mediated uptake and contradictions to the free drug hypothesis: a critical review. Drug Metabolism Reviews 55:3, pages 205-238.
Read now
Read now
Simon J. Carter, Alex S. Ferecskó, Lloyd King, Karelle Ménochet, Ted Parton & Michael J. Chappell. (2020) A mechanistic modelling approach for the determination of the mechanisms of inhibition by cyclosporine on the uptake and metabolism of atorvastatin in rat hepatocytes using a high throughput uptake method. Xenobiotica 50:4, pages 415-426.
Read now
Read now
Michel Bteich, Patrick Poulin & Sami Haddad. (2019) The potential protein-mediated hepatic uptake: discussion on the molecular interactions between albumin and the hepatocyte cell surface and their implications for the in vitro-to-in vivo extrapolations of hepatic clearance of drugs. Expert Opinion on Drug Metabolism & Toxicology 15:8, pages 633-658.
Read now
Read now
Takashi Koyanagi, Koji Yano, Soonih Kim, Norie Murayama, Hiroshi Yamazaki & Ikumi Tamai. (2019) In vivo hepatic clearance of lipophilic drugs predicted by in vitro uptake data into cryopreserved hepatocytes suspended in sera of rats, guinea pigs, monkeys and humans. Xenobiotica 49:8, pages 887-894.
Read now
Read now
Andrew Rowland, David Hallifax, Matthew R. Nussio, Joseph G. Shapter, Peter I. Mackenzie, J. Brian Houston, Kathleen M. Knights & John O. Miners. (2015) Characterization of the comparative drug binding to intra- (liver fatty acid binding protein) and extra- (human serum albumin) cellular proteins. Xenobiotica 45:10, pages 847-857.
Read now
Read now
Leslie C Bell & Jianling Wang. (2012) Probe ADME and Test Hypotheses: a PATH beyond clearance in vitro–in vivo correlations in early drug discovery. Expert Opinion on Drug Metabolism & Toxicology 8:9, pages 1131-1155.
Read now
Read now
Young H. Choi & Myung G. Lee. (2012) Pharmacokinetic and pharmacodynamic interaction between nifedipine and metformin in rats: competitive inhibition for metabolism of nifedipine and metformin by each other via CYP isozymes. Xenobiotica 42:5, pages 483-495.
Read now
Read now
Joanne A. Foster, J. Brian Houston & David Hallifax. (2011) Comparison of intrinsic clearances in human liver microsomes and suspended hepatocytes from the same donor livers: clearance-dependent relationship and implications for prediction of in vivo clearance. Xenobiotica 41:2, pages 124-136.
Read now
Read now
U. Fagerholm. (2009) Presentation of a modified dispersion model (MDM) for hepatic drug extraction and a new methodology for the prediction of the rate-limiting step in hepatic metabolic clearance. Xenobiotica 39:1, pages 57-71.
Read now
Read now
Articles from other publishers (66)
Zhongyuan Cai, Lingling Jiang, Yingzi Cao, Shengxiang Fu, Shasha Wang, Yuting Jiang, Haojie Gu, Na Li, Xiaomin Fu, Shimin Tang, Jiang Zhu, Weidong Cao, Lei Zhong, Zhuzhong Cheng, Chunchao Xia, Su Lui, Bin Song, Qiyong Gong & Hua Ai. (2024) Lipophilic Group-Modified Manganese(II)-Based Contrast Agents for Vascular and Hepatobiliary Magnetic Resonance Imaging. Journal of Medicinal Chemistry 67:6, pages 5011-5031.
Crossref
Crossref
Hequn Li, Fazila Bunglawala, Nicola J Hewitt, Ruth Pendlington, Richard Cubberley, Beate Nicol, Sandrine Spriggs, Maria Baltazar, Sophie Cable & Matthew Dent. (2023) ADME characterization and PBK model development of 3 highly protein-bound UV filters through topical application. Toxicological Sciences 196:1, pages 1-15.
Crossref
Crossref
Julia A. Schulz Pauly, Jin Wang, Colin J. Phipps & John Cory Kalvass. (2023) Assumptions Underlying Hepatic Clearance Models: Recognizing the Influence of Saturable Protein Binding on Driving Force Concentration and Discrimination Between Models of Hepatic Clearance. Drug Metabolism and Disposition 51:8, pages 1046-1052.
Crossref
Crossref
S. Sharma, S. Kumar, V. Kumar & R. Sharma. (2021) Pesticides and vegetables: ecological and metabolic fate with their field and food significance. International Journal of Environmental Science and Technology 20:2, pages 2267-2292.
Crossref
Crossref
Tien-Yu Chang, Hong-Jaan Wang, Shu-Hao Hsu, Ming-Ling Chang, Li-Ting Kao & Li-Heng Pao. (2022) Evidence of the need for modified well-stirred model in vitro to in vivo extrapolation. European Journal of Pharmaceutical Sciences 177, pages 106268.
Crossref
Crossref
Sarah Alrubia, Jialin Mao, Yuan Chen, Jill Barber & Amin Rostami-Hodjegan. (2022) Altered Bioavailability and Pharmacokinetics in Crohn’s Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs. Clinical Pharmacokinetics 61:10, pages 1365-1392.
Crossref
Crossref
Marie-Christine Milot, Ophélie Bélissant Benesty, Véronique Dumulon-Perreault, Samia Ait-Mohand, Patrick O. Richard, Étienne Rousseau & Brigitte Guérin. (2022) 64Cu-DOTHA2-PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window. Pharmaceuticals 15:8, pages 996.
Crossref
Crossref
William J. Jusko & Xiaonan Li. (2021) Assessment of the Kochak-Benet Equation for Hepatic Clearance for the Parallel-Tube Model: Relevance of Classic Clearance Concepts in PK and PBPK. The AAPS Journal 24:1.
Crossref
Crossref
Largee Biswas, Asiya Mahtab & Anita K. Verma. 2022. Nanoparticle Therapeutics. Nanoparticle Therapeutics
265
289
.
Bret BernerRichard N. Upton, Ashley M. Hopkins, Ahmad Y. Abuhelwa, Jim H. Hughes & David J.R. Foster. 2021. Drug Delivery Approaches. Drug Delivery Approaches
43
73
.
Michel Bteich, Patrick Poulin & Sami Haddad. (2021) Comparative Assessment of Extrapolation Methods Based on the Conventional Free Drug Hypothesis and Plasma Protein-Mediated Hepatic Uptake Theory for the Hepatic Clearance Predictions of Two Drugs Extensively Bound to Both the Albumin And Alpha-1-Acid Glycoprotein. Journal of Pharmaceutical Sciences 110:3, pages 1385-1391.
Crossref
Crossref
Nihan Izat & Selma Sahin. (2021) Hepatic transporter‐mediated pharmacokinetic drug–drug interactions: Recent studies and regulatory recommendations. Biopharmaceutics & Drug Disposition 42:2-3, pages 45-77.
Crossref
Crossref
Daniela Schneider, Angela Oskamp, Marcus Holschbach, Bernd Neumaier, Dirk Bier & Andreas Bauer. (2020) Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A1 adenosine receptor. Nuclear Medicine and Biology 82-83, pages 1-8.
Crossref
Crossref
Gergő Dargó, Dávid Bajusz, Kristóf Simon, Judit Müller & György T. Balogh. (2020) Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design. Journal of Medicinal Chemistry 63:4, pages 1763-1774.
Crossref
Crossref
Glen Ernst, Daniel Akuma, Vinh Au, Ingrid P. Buchler, Spencer Byers, Gregory V. Carr, Sabine Defays, Pablo de León, Thierry Demaude, Michael DePasquale, Véronique Durieu, Yifang Huang, Emilie Jigorel, Martha Kimos, Anna Kolobova, Florian Montel, Florence Moureau, Michael Poslusney, Dominique Swinnen, Marie-Christine Vandergeten, Nathalie Van houtvin, Huijun Wei, Noelle White, Martyn Wood & James C. Barrow. (2019)
Synthesis and Evaluation of Bicyclic Hydroxypyridones as Inhibitors of Catechol
O
-Methyltransferase
. ACS Medicinal Chemistry Letters 10:11, pages 1573-1578.
Crossref
Crossref
Christine M. Bowman & Leslie Z. Benet. (2019) Interlaboratory Variability in Human Hepatocyte Intrinsic Clearance Values and Trends with Physicochemical Properties. Pharmaceutical Research 36:8.
Crossref
Crossref
Katrina L. Mealey, Stephanie E. Martinez, Nicolas F. Villarino & Michael H. Court. (2019) Personalized medicine: going to the dogs?. Human Genetics 138:5, pages 467-481.
Crossref
Crossref
Daniela Schneider, Angela Oskamp, Marcus Holschbach, Bernd Neumaier, Andreas Bauer & Dirk Bier. (2019) Relevance of In Vitro Metabolism Models to PET Radiotracer Development: Prediction of In Vivo Clearance in Rats from Microsomal Stability Data. Pharmaceuticals 12:2, pages 57.
Crossref
Crossref
Nicky Helsen, Tom Vervoort, Joris Vandenbossche, Oliver Lenz, Mario Monshouwer, Frederik Pauwels & Jan Snoeys. (2018) Effect of Plasma Protein Binding on the Anti-Hepatitis B Virus Activity and Pharmacokinetic Properties of NVR 3-778. Antimicrobial Agents and Chemotherapy 62:11.
Crossref
Crossref
C.M. Bowman & L.Z. Benet. (2018) An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation. European Journal of Pharmaceutical Sciences 123, pages 502-514.
Crossref
Crossref
Sophia Krause & Kai-Uwe Goss. (2018) The impact of desorption kinetics from albumin on hepatic extraction efficiency and hepatic clearance: a model study. Archives of Toxicology 92:7, pages 2175-2182.
Crossref
Crossref
Kana Horiuchi, Shuichi Ohnishi, Takanobu Matsuzaki, Satoko Funaki, Ayahisa Watanabe, Tohru Mizutare, Sayaka Matsumoto, Ken-ichi Nezasa & Hiroshi Hasegawa. (2018) Improved Human Pharmacokinetic Prediction of Hepatically Metabolized Drugs With Species-Specific Systemic Clearance. Journal of Pharmaceutical Sciences 107:5, pages 1443-1453.
Crossref
Crossref
Lixia Sun, Hongbin Yang, Jie Li, Tianduanyi Wang, Weihua Li, Guixia Liu & Yun Tang. (2017) In Silico Prediction of Compounds Binding to Human Plasma Proteins by QSAR Models. ChemMedChem 13:6, pages 572-581.
Crossref
Crossref
Wolfgang Larisch, Trevor N. Brown & Kai‐Uwe Goss. (2016) A toxicokinetic model for fish including multiphase sorption features. Environmental Toxicology and Chemistry 36:6, pages 1538-1546.
Crossref
Crossref
Jie Gao, Xin Tian, Jun Zhou, Ming-Zhu Cui, Hai-Feng Zhang, Na Gao, Qiang Wen & Hai-Ling Qiao. (2017) From Genotype to Phenotype: Cytochrome P450 2D6-Mediated Drug Clearance in Humans. Molecular Pharmaceutics 14:3, pages 649-657.
Crossref
Crossref
Stevan P. Tofovic & Evan Kharasch. 2017. Smith's Anesthesia for Infants and Children. Smith's Anesthesia for Infants and Children
168
185.e2
.
Richard N. Upton, David J.R. Foster & Ahmad Y. Abuhelwa. (2016) An introduction to physiologically‐based pharmacokinetic models. Pediatric Anesthesia 26:11, pages 1036-1046.
Crossref
Crossref
Min Ye, Swati Nagar & Ken Korzekwa. (2016) A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein‐bound drugs and the impact of errors in plasma protein binding. Biopharmaceutics & Drug Disposition 37:3, pages 123-141.
Crossref
Crossref
Patrick Poulin, Frank J. Burczynski & Sami Haddad. (2016) The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro -to- In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research. Journal of Pharmaceutical Sciences 105:2, pages 497-508.
Crossref
Crossref
Ping Li, Yiran Fan, Yunlong Wang, Yaxin Lu & Zheng Yin. (2015) Characterization of plasma protein binding dissociation with online SPE-HPLC. Scientific Reports 5:1.
Crossref
Crossref
Karen Rowland-Yeo & Geoffrey T. Tucker. 2015. New Horizons in Predictive Drug Metabolism and Pharmacokinetics. New Horizons in Predictive Drug Metabolism and Pharmacokinetics
283
308
.
Floris A. Groothuis, Minne B. Heringa, Beate Nicol, Joop L.M. Hermens, Bas. J. Blaauboer & Nynke I. Kramer. (2015) Dose metric considerations in in vitro assays to improve quantitative in vitro–in vivo dose extrapolations. Toxicology 332, pages 30-40.
Crossref
Crossref
AM Hopkins, MD Wiese, SM Proudman, CE O'Doherty, DJR Foster & RN Upton. (2015) Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients. CPT: Pharmacometrics & Systems Pharmacology 4:6, pages 362-371.
Crossref
Crossref
Mary Courtney Moore, Marta S. Smith, Vikram P. Sinha, John M. Beals, M. Dodson Michael, Scott J. Jacober & Alan D. Cherrington. (2014) Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism. Diabetes 63:2, pages 494-504.
Crossref
Crossref
M. Jamei, F. Bajot, S. Neuhoff, Z. Barter, J. Yang, A. Rostami-Hodjegan & K. Rowland-Yeo. (2013) A Mechanistic Framework for In Vitro–In Vivo Extrapolation of Liver Membrane Transporters: Prediction of Drug–Drug Interaction Between Rosuvastatin and Cyclosporine. Clinical Pharmacokinetics 53:1, pages 73-87.
Crossref
Crossref
Aleksandra Galetin. 2014. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
255
288
.
Leonid M. Berezhkovskiy, Susan Wong & Jason S. Halladay. (2013) On the maintenance of hepatocyte intracellular pH 7.0 in the in-vitro metabolic stability assay. Journal of Pharmacokinetics and Pharmacodynamics 40:6, pages 683-689.
Crossref
Crossref
Evan D. Kharasch. 2011. Anesthetic Pharmacology. Anesthetic Pharmacology
72
89
.
Patricio Godoy, Nicola J. Hewitt, Ute Albrecht, Melvin E. Andersen, Nariman Ansari, Sudin Bhattacharya, Johannes Georg Bode, Jennifer Bolleyn, Christoph Borner, Jan Böttger, Albert Braeuning, Robert A. Budinsky, Britta Burkhardt, Neil R. Cameron, Giovanni Camussi, Chong-Su Cho, Yun-Jaie Choi, J. Craig Rowlands, Uta Dahmen, Georg Damm, Olaf Dirsch, María Teresa Donato, Jian Dong, Steven Dooley, Dirk Drasdo, Rowena Eakins, Karine Sá Ferreira, Valentina Fonsato, Joanna Fraczek, Rolf Gebhardt, Andrew Gibson, Matthias Glanemann, Chris E. P. Goldring, María José Gómez-Lechón, Geny M. M. Groothuis, Lena Gustavsson, Christelle Guyot, David Hallifax, Seddik Hammad, Adam Hayward, Dieter Häussinger, Claus Hellerbrand, Philip Hewitt, Stefan Hoehme, Hermann-Georg Holzhütter, J. Brian Houston, Jens Hrach, Kiyomi Ito, Hartmut Jaeschke, Verena Keitel, Jens M. Kelm, B. Kevin Park, Claus Kordes, Gerd A. Kullak-Ublick, Edward L. LeCluyse, Peng Lu, Jennifer Luebke-Wheeler, Anna Lutz, Daniel J. Maltman, Madlen Matz-Soja, Patrick McMullen, Irmgard Merfort, Simon Messner, Christoph Meyer, Jessica Mwinyi, Dean J. Naisbitt, Andreas K. Nussler, Peter Olinga, Francesco Pampaloni, Jingbo Pi, Linda Pluta, Stefan A. Przyborski, Anup Ramachandran, Vera Rogiers, Cliff Rowe, Celine Schelcher, Kathrin Schmich, Michael Schwarz, Bijay Singh, Ernst H. K. Stelzer, Bruno Stieger, Regina Stöber, Yuichi Sugiyama, Ciro Tetta, Wolfgang E. Thasler, Tamara Vanhaecke, Mathieu Vinken, Thomas S. Weiss, Agata Widera, Courtney G. Woods, Jinghai James Xu, Kathy M. Yarborough & Jan G. Hengstler. (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Archives of Toxicology 87:8, pages 1315-1530.
Crossref
Crossref
Miyoung Yoon, Harvey J. ClewellIIIIII & Melvin E. Andersen. (2013) Deriving an explicit hepatic clearance equation accounting for plasma protein binding and hepatocellular uptake. Toxicology in Vitro 27:1, pages 11-15.
Crossref
Crossref
Li Di, Christopher Keefer, Dennis O. Scott, Timothy J. Strelevitz, George Chang, Yi-An Bi, Yurong Lai, Jonathon Duckworth, Katherine Fenner, Matthew D. Troutman & R. Scott Obach. (2012) Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design. European Journal of Medicinal Chemistry 57, pages 441-448.
Crossref
Crossref
Alexander V. LyubimovRichard J. Dimelow, Paul D. Metcalfe & Simon Thomas. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
55
.
Leonid M. Berezhkovskiy. (2012) Determination of Hepatic Clearance with the Account of Drug–Protein Binding Kinetics. Journal of Pharmaceutical Sciences 101:10, pages 3936-3945.
Crossref
Crossref
David Hallifax & J. Brian Houston. (2012) Evaluation of Hepatic Clearance Prediction Using In Vitro Data: Emphasis on Fraction Unbound in Plasma and Drug Ionisation Using a Database of 107 Drugs. Journal of Pharmaceutical Sciences 101:8, pages 2645-2652.
Crossref
Crossref
Guoyu Pan, Carri Boiselle & Jianling Wang. (2012) Assessment of Biliary Clearance in Early Drug Discovery using Sandwich-cultured Hepatocyte Model. Journal of Pharmaceutical Sciences 101:5, pages 1898-1908.
Crossref
Crossref
Karelle Ménochet, Kathryn E. Kenworthy, J. Brian Houston & Aleksandra Galetin. (2012) Simultaneous Assessment of Uptake and Metabolism in Rat Hepatocytes: A Comprehensive Mechanistic Model. Journal of Pharmacology and Experimental Therapeutics 341:1, pages 2-15.
Crossref
Crossref
David Hallifax, Elisa Turlizzi, Ugo Zanelli & J. Brian Houston. (2012) Clearance-dependent underprediction of in vivo intrinsic clearance from human hepatocytes: Comparison with permeabilities from artificial membrane (PAMPA) assay, in silico and caco-2 assay, for 65 drugs. European Journal of Pharmaceutical Sciences 45:5, pages 570-574.
Crossref
Crossref
Samantha Forster, Alfred E. Thumser, Steve R. Hood & Nick Plant. (2012) Characterization of Rhodamine-123 as a Tracer Dye for Use In In vitro Drug Transport Assays. PLoS ONE 7:3, pages e33253.
Crossref
Crossref
Shu-Feng Zhou. 2012. Materia Medica for Various Cancers. Materia Medica for Various Cancers
353
395
.
Joachim Bucher, Stephan Riedmaier, Anke Schnabel, Katrin Marcus, Gabriele Vacun, Thomas S Weiss, Wolfgang E Thasler, Andreas K Nüssler, Ulrich M Zanger & Matthias Reuss. (2011) A systems biology approach to dynamic modeling and inter-subject variability of statin pharmacokinetics in human hepatocytes. BMC Systems Biology 5:1.
Crossref
Crossref
Thomas R.B. Grandjean, Mike J. Chappell, James T.W. Yates, Kevin Jones, Gemma Wood & Tanya Coleman. (2011) Compartmental modelling of the pharmacokinetics of a breast cancer resistance protein. Computer Methods and Programs in Biomedicine 104:2, pages 81-92.
Crossref
Crossref
Leonid M. Berezhkovskiy. (2011) The influence of hepatic transport on the distribution volumes and mean residence time of drug in the body and the accuracy of estimating these parameters by the traditional pharmacokinetic calculations. Journal of Pharmaceutical Sciences 100:11, pages 5031-5047.
Crossref
Crossref
Shahab Sheikh-Bahaei & C. Anthony Hunt. (2011) Enabling Clearance Predictions to Emerge from In Silico Actions of Quasi-Autonomous Hepatocyte Components. Drug Metabolism and Disposition 39:10, pages 1910-1920.
Crossref
Crossref
Leonid M. Berezhkovskiy. (2011) The Corrected Traditional Equations for Calculation of Hepatic Clearance that Account for the Difference in Drug Ionization in Extracellular and Intracellular Tissue Water and the Corresponding Corrected PBPK Equation. Journal of Pharmaceutical Sciences 100:3, pages 1167-1183.
Crossref
Crossref
Peter J. Davis, Adrian Bosenberg, Andrew Davidson, Nathalia Jimenez, Evan Kharasch, Anne M. Lynn, Stevan P. Tofovic & Susan Woelfel. 2011. Smith's Anesthesia for Infants and Children. Smith's Anesthesia for Infants and Children
179
261
.
David Hallifax, Joanne A. Foster & J. Brian Houston. (2010) Prediction of Human Metabolic Clearance from In Vitro Systems: Retrospective Analysis and Prospective View. Pharmaceutical Research 27:10, pages 2150-2161.
Crossref
Crossref
Vikram Ramanathan & Nimish Vachharajani. 2009. Evaluation of Drug Candidates for Preclinical Development. Evaluation of Drug Candidates for Preclinical Development
135
167
.
Christopher J. Endres, Michael G. Endres & Jashvant D. Unadkat. (2009) Interplay of Drug Metabolism and Transport: A Real Phenomenon or an Artifact of the Site of Measurement?. Molecular Pharmaceutics 6:6, pages 1756-1765.
Crossref
Crossref
K. A. CORTRIGHT, S. E. WETZLICH & A. L. CRAIGMILL. (2009) A PBPK model for midazolam in four avian species. Journal of Veterinary Pharmacology and Therapeutics 32:6, pages 552-565.
Crossref
Crossref
John W. Nichols, Alex D. Hoffman & Patrick N. Fitzsimmons. (2009) Optimization of an isolated perfused rainbow trout liver model: Clearance studies with 7-ethoxycoumarin. Aquatic Toxicology 95:3, pages 182-194.
Crossref
Crossref
Christopher Kohl. (2009) Transporters – The View from Industry. Chemistry & Biodiversity 6:11, pages 1988-1999.
Crossref
Crossref
Masato Chiba, Yasuyuki Ishii & Yuichi Sugiyama. (2009) Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug Development. The AAPS Journal 11:2.
Crossref
Crossref
Mei-Ling Chen & Lawrence Yu. (2009) The Use of Drug Metabolism for Prediction of Intestinal Permeability. Molecular Pharmaceutics 6:1, pages 74-81.
Crossref
Crossref
Thomas R.B. Grandjean, Mike J. Chappell, James T.W. Yates, Kevin Jones, Gemma Wood & Tanya Coleman. (2009) Compartmental Modelling of the Pharmacokinetics of a Breast Cancer Resistance Protein. IFAC Proceedings Volumes 42:12, pages 115-120.
Crossref
Crossref
Masoud Jamei, Gemma L. Dickinson & Amin Rostami-Hodjegan. (2009) A Framework for Assessing Inter-individual Variability in Pharmacokinetics Using Virtual Human Populations and Integrating General Knowledge of Physical Chemistry, Biology, Anatomy, Physiology and Genetics: A Tale of ‘Bottom-Up’ vs ‘Top-Down’ Recognition of Covariates. Drug Metabolism and Pharmacokinetics 24:1, pages 53-75.
Crossref
Crossref
Agnès Poirier, Thierry Lavé, Renée Portmann, Marie-Elise Brun, Frank Senner, Manfred Kansy, Hans-Peter Grimm & Christoph Funk. (2008) Design, Data Analysis, and Simulation of in Vitro Drug Transport Kinetic Experiments Using a Mechanistic in Vitro Model. Drug Metabolism and Disposition 36:12, pages 2434-2444.
Crossref
Crossref